Cara Therapeutics (CARA) stock price prediction is USD. The Cara Therapeutics stock forecast is USD for August Cara Therapeutics (CARA) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with. The 2 analysts with month price forecasts for Cara Therapeutics stock have an average target of , which predicts an increase of % from the current. What is the CARA Therapeutics stock forecast? The CARA Therapeutics stock forecast for tomorrow is $ , which would represent a % gain compared to.
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CARA is experiencing. Average Target Price, ; Number Of Ratings, 5 ; FY Report Date, 12/ ; Last Quarter's Earnings, ; Year Ago Earnings, The average price target is $1 with a high estimate of $1 and a low estimate of $1. Sign in to your SmartPortfolio to see more analyst recommendations. What is the Cara Therapeutics stock price / share price today? The Cara Therapeutics stock price is USD today. Will CARA stock price drop / fall? Yes. Research Cara Therapeutics' (Nasdaq:CARA) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and. CARA / Cara Therapeutics, Inc. (NasdaqCM) - Forecast, Price Target, Estimates, Predictions. For the upcoming trading day on Tuesday, 3rd we expect Cara Therapeutics to open at $, and during the day (based on 14 day Average True Range), to move. Price Target. Argus• last year. What does Argus have to say about CARA? CARA THERAPEUTICS INC has an Investment Rating of SELL; a target price of $ CARA Sales Forecast. Next quarter's sales forecast for CARA is $M with a range of $M to $M. The previous quarter's sales results were $K. CARA. On average, Wall Street analysts predict that Cara Therapeutics's share price could reach $ by Jun 13, The average Cara Therapeutics stock price. Cara Therapeutics Inc has a consensus price target of $ based on the ratings of 9 analysts. The high is $28 issued by Stifel on June 27,
Get Cara Therapeutics Inc (CARA:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Price Target. Argus• last year. What does Argus have to say about CARA? CARA THERAPEUTICS INC has an Investment Rating of SELL; a target price of $ According to analysts, CARA price target is USD with a max estimate of USD and a min estimate of USD. Check if this forecast comes true in a year. Cara Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. CARA updated stock price target summary. The 29 analysts offering price forecasts for Cara Therapeutics have a median target of , with a high estimate of and a low estimate of Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. Bid Price and Ask Price. The bid & ask refers to the price that an. The average price target for Cara Therapeutics comes to $ The forecasts range from a low of $ to a high of $ Cara Therapeutics stock up % after company announces positive Phase 3 data for itchiness treatment. CARA's current price target is $ Learn why top analysts are making this stock forecast for Cara Therapeutics at MarketBeat.
Cara Therapeutics Inc. ; Open. $ Previous Close ; YTD Change. %. 12 Month Change ; Day Range · 52 Wk Range. View Cara Therapeutics Inc CARA stock quote prices, financial information, real-time forecasts, and company news from CNN. The stock price for Cara Therapeutics (NASDAQ: CARA) is $ last updated August 28, at PM EDT. Q. Does Cara Therapeutics (CARA) pay a dividend? A. Over the last 12 months, its price fell by percent. Looking ahead, we forecast Cara Therapeutics to be priced at by the end of this quarter and at. Track Cara Therapeutics Inc (CARA) Stock Price, Quote, latest community messages, chart, news and other stock related information.
According to analysts, CARA price target is USD with a max estimate of USD and a min estimate of USD. Check if this forecast comes true in a year. Get Cara Therapeutics Inc (CARA:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Cara Therapeutics (CARA) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. (NASDAQ: CARA) Cara Therapeutics currently has 54,, outstanding shares. With Cara Therapeutics stock trading at $ per share, the total value of Cara. Warren Buffett is divesting from Apple and investing in a different mega-cap stock. AT&T and Altria Group are being compared as high-yield dividend stock. CARA: Lowering target price to $ CARA: What does Argus have to say about CARA? Neutral. Research Cara Therapeutics' (Nasdaq:CARA) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and. CARA's current price target is $ Learn why top analysts are making this stock forecast for Cara Therapeutics at MarketBeat. The 2 analysts with month price forecasts for Cara Therapeutics stock have an average target of , which predicts an increase of % from the current. For the upcoming trading day on Monday, 16th we expect Cara Therapeutics to open at $, and during the day (based on 14 day Average True Range), to move. How To Buy Cara Therapeutics Inc. (CARA) Shares It currently costs $ to buy one share in Cara Therapeutics Inc. (as of 02/08/ ) which is a change. Cara Therapeutics Inc has a consensus price target of $ based on the ratings of 9 analysts. The high is $28 issued by Stifel on June 27, The 29 analysts offering price forecasts for Cara Therapeutics have a median target of , with a high estimate of and a low estimate of US · Evolution of the Average Target: Cara Therapeutics, Inc. · Evolution of the Target Price: Cara Therapeutics, Inc. · Changes in Analyst. Cara Therapeutic (CARA) stock price prediction is USD. The Cara Therapeutic stock forecast is USD for September Cara is projected to decline in value after the next headline, with the price expected to drop to The average volatility of media hype impact on the. On average, Wall Street analysts predict that Cara Therapeutics's share price could reach $ by Jun 13, The average Cara Therapeutics stock price. Like earnings, a higher growth rate is better than a lower growth rate. Seeing a company's projected sales growth instantly tells you what the outlook is for. The stock price for Cara Therapeutics (NASDAQ: CARA) is $ last updated September 13, at PM EDT. Q. Does Cara Therapeutics (CARA) pay a dividend? A. View the CARA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Cara Therapeutic real. Based on short-term price targets offered by four analysts, the average price target for Cara Therapeutics comes to $ The forecasts range from a low of. Is Cara Therapeutics Stock Undervalued? The current Cara Therapeutics [CARA] share price is $ The Score for CARA is 10, which is 80% below its historic. Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with. Stock Price Targets. High, $ Median, $ Low, $ Average, $ Current Price, $ Yearly Numbers. Estimates. CARA will report earnings. UPDATE: Cara Therapeutics stock surges 34% on news of positive results in trial of post-surgery pain treatment. Over the last 12 months, its price fell by percent. Looking ahead, we forecast Cara Therapeutics to be priced at by the end of this quarter and at. What is the Cara Therapeutics stock price / share price today? The Cara Therapeutics stock price is USD today. Will CARA stock price drop / fall? Yes. The CARA Therapeutics stock forecast for tomorrow is $ , which would represent a % gain compared to the current price. In the next week, the price. The average price target is $1 with a high estimate of $1 and a low estimate of $1. Sign in to your SmartPortfolio to see more analyst recommendations. View Cara Therapeutics Inc CARA stock quote prices, financial information, real-time forecasts, and company news from CNN.
CARA - Cara Therapeutics, Inc. (NasdaqCM) - Share Price and News. Cara Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing therapeutics treatment of chronic pruritus in. Analyst. Target Price. · 5 analysts ; Earnings. EPS Forecast. Up. Next quarter ; Investor. New Investor. Acuitas Investments, LLC. +% Portfolio. Tomorrow's movement Prediction of Cara Therapeutics, Inc. CARA is strongly bearish. It has broken a strong support of 2 and is expected to move down further. AI. Cara Therapeutic (CARA) · Volume: , · Bid/Ask: / · Day's Range: - As on 26th Jul CARA STOCK Price closed @ and we RECOMMEND N/A for LONG-TERM with Stoploss of & N/A for SHORT-TERM with Stoploss of we also.